Indegene is forecast to grow earnings and revenue by 21.3% and 15.1% per annum respectively. EPS is expected to grow by 20.4% per annum. Return on equity is forecast to be 16.4% in 3 years.
Key information
21.3%
Earnings growth rate
20.45%
EPS growth rate
Life Sciences earnings growth
23.9%
Revenue growth rate
15.1%
Future return on equity
16.37%
Analyst coverage
Low
Last updated
07 Jul 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
BSE:544172 - Analysts future estimates and past financials data (INR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2029
56,884
7,721
7,486
7,813
2
3/31/2028
48,374
6,502
6,830
7,675
5
3/31/2027
42,947
5,177
4,815
6,253
5
3/31/2026
35,105
4,011
6,065
6,508
N/A
12/31/2025
32,627
4,390
N/A
N/A
N/A
9/30/2025
30,410
4,458
4,683
5,094
N/A
6/30/2025
29,236
4,354
N/A
N/A
N/A
3/31/2025
28,393
4,067
4,119
4,419
N/A
12/31/2024
27,567
3,839
N/A
N/A
N/A
9/30/2024
27,097
3,730
4,302
4,377
N/A
6/30/2024
26,586
3,560
N/A
N/A
N/A
3/31/2024
25,896
3,367
4,970
5,077
N/A
12/31/2023
25,489
2,907
3,871
4,100
N/A
6/30/2023
23,927
2,487
N/A
N/A
N/A
3/31/2023
23,061
2,661
1,114
1,302
N/A
3/31/2022
16,646
1,648
2,723
2,970
N/A
3/31/2021
9,806
1,857
1,514
1,720
N/A
3/31/2020
6,436
558
162
223
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 544172's forecast earnings growth (21.3% per year) is above the savings rate (6.9%).
Earnings vs Market: 544172's earnings (21.3% per year) are forecast to grow faster than the Indian market (16.3% per year).
High Growth Earnings: 544172's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 544172's revenue (15.1% per year) is forecast to grow faster than the Indian market (11.1% per year).
High Growth Revenue: 544172's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 544172's Return on Equity is forecast to be low in 3 years time (16.4%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/15 11:36
End of Day Share Price
2026/07/15 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Indegene Limited is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.